Gregg Peterson

Chief Executive Officer & Director at Bexson Biomedical

Gregg has over 20 years of experience developing pharmaceutical, medical device, biologic and combination products, leading to launch of 12 products globally. He was previously a Global R&D Program Lead for S&P500 company with a focus on US, EU and AsiaPac. He has a successful history directing R&D programs from market need analysis and ideation, through Phase III clinical trials, and to regulatory approval. Gregg is a veteran of multiple startup companies including Evolus (IPO), TargeGen (sale to Sanofi-Aventis) and Somaxon (IPO). He holds a B.S. from University of Puget Sound and a M.A. from the Medical College of Wisconsin.


  • Chief Executive Officer & Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.